Equivalent to 125 mg ceftiofur per 10 ml syringe.

Indicated for use in lactating dairy cattle for the treatment of clinical mastitis associated with coagulase-negative staphylococci, Streptococcus dysgalactiae and E. coli, as well as the treatment of diagnosed subclinical mastitis associated with coagulase-negative staphylococci and Streptococcus dysgalactiae.

SPECTRAMAST® LC has flexible label mastitis therapy to help tailor treatment duration to the individual case of mastitis when extra days of therapy are needed. Provides the flexibility to continue once-daily treatment for up to 8 consecutive days for more stubborn mastitis cases.

Benefits of SPECTRAMAST® LC include:

• A two-day pre-slaughter meat withdrawal – the shortest withhold time available for greater management flexibility
• A 70.4% bacteriological cure rate achieved with just 2 syringes of SPECTRAMAST® LC, according to research*

* Data on file, Study Report No. a0091969, Zoetis Inc.

A Cornell University study evaluated the efficacy of SPECTRAMAST® LC for treating mild and moderate cases of gram-negative mastitis.**

• Cows with complete cures gave 8.8 pounds more milk compared with cows not cured (p < 0.05)**
• Bacteriological cure rate for quarters infected with E. coli was 89% in cows treated with SPECTRAMAST® LC versus 53% in cows receiving no treatment**

** Schukken YH, Bennett GJ, Zurakowski MJ, et al. Randomized clinical trial to evaluate the efficacy of a 5-day ceftiofur

Residue Free Guarantee Program: If you use a Zoetis-branded ceftiofur product according to label indications, and experience a violative ceftiofur milk or meat residue, Zoetis will compensate you for the beef market value of the animal or purchase the tanker of milk at fair market value. To qualify, you must purchase the product from a Zoetis-approved supplier, use the product according to label directions, have documentation of the product purchase and treatment records. Extra-label use as prescribed by a veterinarian is excluded from the guarantee.